GIST SUPPORT UK is a member of Cancer52 who are an alliance of nearly 100 rare cancer groups.
Cancer52 members have been approached by the research team at the Sir William Dunn School of Pathology, University of Oxford, who are working on a European funded rare cancer initiative that seeks to find and develop innovative solutions to aid the current disadvantages rare cancer patients face. They are currently focused on collecting feedback on rare cancer patient experience with clinical trials.
The team has created a survey for rare cancer patients, anonymised and completed in less than 6 minutes, which will help them to get an idea of the real issues that need to be addressed.
To complete the survey please go to https://www.surveymonkey.co.uk/r/JNSLVTL.
The information provided for this survey is to be viewed and used by The Rare Cancer Project, Oxford University for research purposes only.
No commercial company has been involved in the creation of this survey.
Thank you for adding GIST patient experience to this survey.